These findings reinforce the importance of oxidative stress and protease/antiprotease imbalance in emphysema development and suggest oxidative stress, MMP-12, and neutrophil elastase as a future targets for emphysema therapy. The gene discussed is ELANE; the disease is pulmonary emphysema.